Stay updated on Elranatamab Combo in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page no longer shows a MedlinePlus Genetics link associated with multiple myeloma information.
    Difference
    0.1%
    Check dated 2026-11-15T14:30:21.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The record now presents details of the MagnetisMM-6 multiple myeloma trial, including its treatment arms, eligibility criteria, outcome measures, and study locations.
    Difference
    100%
    Check dated 2026-11-08T14:14:26.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:41:36.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice banner was added announcing an NIH website transition and explaining that both “Super Intelligence” and “Artificial Intelligence” terminology may appear during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:30:17.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:08:15.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:57:14.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.